Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia

International Journal of Tuberculosis and Lung Disease

Volumn 6, Issue 7, 2002, Pages 585-591

  Singla, Rupak ^a   Al Sharif, N ^a   Al Sayegh, M O ^a   Osman, M M ^a   Shaikh, M A ^a  

^a Sahary Hospital   (Saudi Arabia)

Author keywords

Drug resistance; Pulmonary tuberculosis; Treatment outcome

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; DIRECTLY OBSERVED THERAPY; FEMALE; FOLLOW UP; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; RELAPSE; SAUDI ARABIA; SHORT COURSE THERAPY; SPUTUM SMEAR; TREATMENT OUTCOME; ISOLATION AND PURIFICATION; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RETROSPECTIVE STUDY; SPUTUM; TUBERCULOSIS;

ADULT; ANTIBIOTICS, ANTITUBERCULAR; ETHAMBUTOL; FEMALE; HUMANS; ISONIAZID; MALE; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RETROSPECTIVE STUDIES; RIFAMPIN; SAUDI ARABIA; SPUTUM; STREPTOMYCIN; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 0036632440     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Al-Kassimi F A, Abdullah A K, Al-Hajjaj M S, Al-Orainey I O, Bamgboye E A, Chowdhury M N. Nationwide community survey of tuberculosis epidemiology in Saudi Arabia. Tubercle Lung Dis 1993; 74: 254-260.
2. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. 2nd ed. WHO/TB/97.220. Geneva: WHO, 1997.
3. Espinal M A, Kim S J, Suarez P G, et al. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcome in six countries. JAMA 2000; 283: 2537-2545.
4. Ellis M E, Al-Hajjar S, Bokhari H, Hussein Qadri S M. High proportion of multi-drug resistant Mycobacterium tuberculosis in Saudi Arabia. Scand J Infect Dis 1996; 28: 591-596.
5. Al-Hajjaj M S, Pandya L, Marie A A, Madani A A, Al-Sharif N, Al-Majed S. Pulmonary tuberculosis in Saudi Arabia: a retrospective study of 1566 patients. Ann Saudi Med 1991; 11: 443-447.
6. Schiott C R, Engbaek H C, Vergmann B, Al-Motez M, Kassim I. Incidence of drug resistance amongst isolates of Mycobacterium tuberculosis recovered in Gizan area, Saudi Arabia. Saudi Med J 1985; 6: 375-378.
7. Kinsara A J. Review of tuberculosis at King Khalid National Guard Hospital, Jeddah (letter). Saudi Med J 1998; 19: 212-214.
8. Al-Rubaish A M, Madania A A, Al-Muhanna F A. Drug resistance pulmonary tuberculosis in the Eastern Province of Saudi Arabia. Saudi Med J 2001; 22: 776-779.
9. Khan M Y, Kinsara A J, Osaba O A, Wali S, Samman Y, Memish Z. Increasing resistance of M. tuberculosis to anti-tuberculosis drugs in Saudi Arabia. Int J Antimicrob Agents 2001; 17: 415-418.
10. Garcia-Garcia M, Ponce-de-Leon A, Jimenez-Corona M, et al. Clinical consequences and transmissibility of drug-resistant tuberculosis in Southern Mexico. Arch Intern Med 2000; 160: 630-636.
11. Coninx R, Mathieu C, Debacker M et al. First-line tuberculosis therapy and drug-resistant Mycobacterium tuberculosis in prisons. Lancet 1999; 353: 969-973.
12. Mitchison D A, Nunn A J. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. Am Rev Respir Dis 1986; 133: 423-430.
13. Aber V R, Nunn A J. Short term chemotherapy of tuberculosis: factors affecting relapses following short term therapy. Bull Int Union Tuberc 1978; 53: 276-280.
14. Feng-zeng Z, Levy M H, Sumin W. Sputum microscopy results at two and three months predict outcome of tuberculosis treatment. Int J Tuberc Lung Dis 1997; 1: 570-572.
15. The World Bank. Investing in Health: World Development Report 1993. New York, NY: Oxford University Press; 1993.
16. World Health Organization, Communicable Diseases Programme. Global Tuberculosis Control. WHO/CDS/TB/2000.275. Geneva: WHO, 2000.